Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors
Josefine Kjaer(Uppsala University), Peter Stålberg(Uppsala University Hospital), Gerhard Doherty(Brigham and Women's Hospital), Lauren K. Brais(Dana-Farber Cancer Institute), Brittany Powell(Brigham and Women's Hospital), Niklas Andersson(University of Gothenburg), William Baddoo(Dana-Farber Cancer Institute), Kristina Astone(Dana-Farber Cancer Institute), Per Hellman(Uppsala University Hospital), Olov Norlén(Uppsala University), Thomas E. Clancy(Brigham and Women's Hospital), Megan L. Sulciner(Brigham and Women's Hospital), Staffan Welin(Uppsala University), Anders Thornell(University of Gothenburg), Jennifer A. Chan(Dana-Farber Cancer Institute), Joakim Crona(Uppsala University)
Cited by 10
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951